Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Ofloxacin's Activity Against Pseudomonas Aeruginosa

Comparison with Other Fluoroquinolones

  • Ciprofloxacin is considered the best oral anti-pseudomonal agent among the fluoroquinolones, with greater potency against Pseudomonas aeruginosa than ofloxacin 1, 2
  • Levofloxacin at high doses has been approved for activity against Pseudomonas aeruginosa, though clinical experience is more limited compared to ciprofloxacin 2

Clinical Applications

  • For respiratory infections where Pseudomonas aeruginosa is suspected, guidelines recommend ciprofloxacin rather than ofloxacin as the preferred fluoroquinolone 1, 2
  • For serious Pseudomonas aeruginosa infections requiring hospitalization, combination therapy with an antipseudomonal beta-lactam plus either an aminoglycoside or an antipseudomonal quinolone is recommended 3

Practical Implications

  • For empiric treatment of infections where Pseudomonas aeruginosa is suspected, ciprofloxacin is generally preferred over ofloxacin due to its greater potency 2